Annual Cash & Cash Equivalents
$2.83 M
-$1.17 M-29.35%
December 31, 2023
Summary
- As of February 12, 2025, ADIL annual cash & cash equivalents is $2.83 million, with the most recent change of -$1.17 million (-29.35%) on December 31, 2023.
- During the last 3 years, ADIL annual cash & cash equivalents has fallen by -$1.57 million (-35.76%).
- ADIL annual cash & cash equivalents is now -58.28% below its all-time high of $6.78 million, reached on December 31, 2019.
Performance
ADIL Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$5.20 M
+$1.92 M+58.28%
September 30, 2024
Summary
- As of February 12, 2025, ADIL quarterly cash and cash equivalents is $5.20 million, with the most recent change of +$1.92 million (+58.28%) on September 30, 2024.
- Over the past year, ADIL quarterly cash and cash equivalents has increased by +$179.20 thousand (+3.57%).
- ADIL quarterly cash and cash equivalents is now -58.99% below its all-time high of $12.69 million, reached on March 31, 2022.
Performance
ADIL Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ADIL Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.4% | +3.6% |
| 3 y3 years | -35.8% | +3.6% |
| 5 y5 years | -26.9% | +3.6% |
ADIL Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -53.4% | at low | -59.0% | +1547.5% |
| 5 y | 5-year | -58.3% | at low | -59.0% | +1547.5% |
| alltime | all time | -58.3% | >+9999.0% | -59.0% | >+9999.0% |
Adial Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.20 M(+58.3%) |
| Jun 2024 | - | $3.29 M(-34.6%) |
| Mar 2024 | - | $5.03 M(+77.7%) |
| Dec 2023 | $2.83 M(-29.4%) | $2.83 M(+794.9%) |
| Sep 2023 | - | $315.90 K(-74.1%) |
| Jun 2023 | - | $1.22 M(-47.3%) |
| Mar 2023 | - | $2.31 M(-42.2%) |
| Dec 2022 | $4.00 M(-34.0%) | $4.00 M(-30.4%) |
| Sep 2022 | - | $5.75 M(-37.2%) |
| Jun 2022 | - | $9.16 M(-27.8%) |
| Mar 2022 | - | $12.69 M(+109.3%) |
| Dec 2021 | $6.06 M(+37.7%) | $6.06 M(-15.6%) |
| Sep 2021 | - | $7.18 M(+37.8%) |
| Jun 2021 | - | $5.21 M(-7.6%) |
| Mar 2021 | - | $5.64 M(+28.1%) |
| Dec 2020 | $4.40 M | $4.40 M(-40.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $7.37 M(-14.6%) |
| Jun 2020 | - | $8.62 M(+74.2%) |
| Mar 2020 | - | $4.95 M(-26.9%) |
| Dec 2019 | $6.78 M(+75.2%) | $6.78 M(-20.5%) |
| Sep 2019 | - | $8.53 M(-16.8%) |
| Jun 2019 | - | $10.25 M(-10.0%) |
| Mar 2019 | - | $11.39 M(+194.5%) |
| Dec 2018 | $3.87 M(>+9900.0%) | $3.87 M(-19.7%) |
| Sep 2018 | - | $4.82 M(+3111.1%) |
| Jun 2018 | - | $150.00 K(+177.8%) |
| Mar 2018 | - | $54.00 K(+196.7%) |
| Dec 2017 | $18.20 K(-79.3%) | $18.20 K(-54.8%) |
| Sep 2017 | - | $40.30 K(-70.6%) |
| Jun 2017 | - | $137.10 K(+55.8%) |
| Dec 2016 | $88.00 K(-45.8%) | $88.00 K |
| Dec 2015 | $162.40 K | - |
FAQ
- What is Adial Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Adial Pharmaceuticals?
- What is Adial Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Adial Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Adial Pharmaceuticals?
- What is Adial Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Adial Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of ADIL is $2.83 M
What is the all time high annual cash & cash equivalents for Adial Pharmaceuticals?
Adial Pharmaceuticals all-time high annual cash & cash equivalents is $6.78 M
What is Adial Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, ADIL annual cash & cash equivalents has changed by -$1.17 M (-29.35%)
What is Adial Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ADIL is $5.20 M
What is the all time high quarterly cash and cash equivalents for Adial Pharmaceuticals?
Adial Pharmaceuticals all-time high quarterly cash and cash equivalents is $12.69 M
What is Adial Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, ADIL quarterly cash and cash equivalents has changed by +$179.20 K (+3.57%)